The Global Ertapenem for Injection Market was valued at USD 480.2 Million in 2023 and is projected to reach USD 682.7 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period (2024–2030). This growth is driven by rising antibiotic-resistant infections, increasing surgical procedures requiring prophylaxis, and expanded healthcare access in developing nations.

As gram-negative bacterial infections become more challenging to treat with conventional antibiotics, ertapenem’s broad-spectrum antibacterial properties position it as a critical therapeutic option. In this analysis, we examine the Top 10 Companies in the Ertapenem for Injection Market—pharmaceutical innovators and manufacturers delivering essential carbapenem therapies globally.

---

🔟 1. Merck & Co., Inc. (MSD)

Headquarters: Kenilworth, New Jersey, USA
Key Offering: Invanz® (ertapenem sodium)

Merck & Co. holds the original patent and trademark for Invanz®, the flagship ertapenem product recognized worldwide. Their formulation is approved for treating complicated intra-abdominal infections, community-acquired pneumonia, acute pelvic infections, and diabetic foot infections.

Key Advantages:

• Pioneering research in carbapenem antibiotics
• Extensive clinical trial database supporting efficacy
• Global manufacturing and distribution capabilities

Download FREE Sample Report:
https://www.24chemicalresearch.com/download-sample/277305/global-ertapenem-for-injection-market-2024-224

---

9️⃣ 2. Savior Lifetec Corporation

Headquarters: Taizhou, China
Key Offering: Generic ertapenem for injection

This Chinese pharmaceutical company has emerged as a major global supplier of generic ertapenem, with production facilities certified to WHO-GMP standards. Their products are registered in over 30 countries across Asia, Africa, and Latin America.

Manufacturing Strengths:

• Annual capacity exceeding 50 million vials
• Robust quality control systems
• Competitive pricing structure

---

8️⃣ 3. ACS Dobfar S.p.A.

Headquarters: Tribiano, Italy
Key Offering: Ertapenem API and finished formulations

ACS Dobfar specializes in antibiotic active pharmaceutical ingredients (APIs), supplying ertapenem sodium to pharmaceutical manufacturers worldwide. Their production meets stringent EU GMP requirements.

Technical Capabilities:

• Vertically integrated manufacturing
• Custom synthesis services
• Stable polymorph development

---

7️⃣ 4. Zhejiang Hisun Pharmaceutical Co., Ltd.

Headquarters: Taizhou, China
Key Offering: Generic ertapenem injections

Hisun Pharma operates China’s largest carbapenem API production facility, supplying both domestic and international markets. The company maintains approvals from FDA, EDQM, and other major regulatory bodies.

Quality Certifications:

• FDA-inspected manufacturing sites
• Certified to supply EU and Japanese markets
• ISO 13485 certification for medical devices

Download FREE Sample Report:
https://www.24chemicalresearch.com/download-sample/277305/global-ertapenem-for-injection-market-2024-224

---

6️⃣ 5. Sun Pharmaceutical Industries Ltd.

Headquarters: Mumbai, India
Key Offering: Etanem (ertapenem for injection)

India’s largest pharmaceutical company markets its branded generic ertapenem across emerging markets, leveraging its extensive distribution network in Asia and Africa.

Strategic Position:

• Established presence in price-sensitive markets
• Integrated API-to-formulation production
• Focus on institutional sales channels

---

5️⃣ 6. Zhejiang Hisoar Pharmaceutical Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Ertapenem API and sterile injections

Hisoar specializes in sterile injectable antibiotics with particular expertise in carbapenem-class drugs. The company has developed proprietary crystallization techniques for enhanced purity.

Technical Expertise:

• Advanced sterile filling capabilities
• High-purity API production
• Lyophilization technology

---

4️⃣ 7. Kaliberr Labs Pvt. Ltd.

Headquarters: Hyderabad, India
Key Offering: Generic ertapenem injections

This Indian pharmaceutical company focuses on critical care injectables, supplying hospitals and institutional buyers through global tender processes.

Regulatory Approvals:

Supply Chain Advantages:

• Approvals in 26 countries
• Cold chain distribution network
• Tender-focused business model

---

3️⃣ 8. Qilu Pharmaceutical Co., Ltd.

Headquarters: Jinan, China
Key Offering: Ertapenem sodium for injection

Qilu operates one of China’s most advanced antibiotic manufacturing facilities, with vertically integrated production from API to finished vials.

Production Metrics:

• Annual API capacity exceeding 50 metric tons
• Automated aseptic filling lines
• Validated sterilization processes

---

2️⃣ 9. Sagent Pharmaceuticals (Nicholas Piramal India Ltd.)

Headquarters: Schaumburg, Illinois, USA
Key Offering: Generic ertapenem for injection

Sagent supplies FDA-approved generic injectable antibiotics to the U.S. healthcare system, with particular focus on hospital distribution channels.

Regulatory Highlights:

• Multiple ANDA approvals
• Ready-to-use presentations
• Strict sterility assurance

---

1️⃣ 10. United Laboratories International Holdings Ltd.

Headquarters: Hong Kong, China
Key Offering: Ertapenem branded generics

Known as “TUL” in pharmaceutical circles, this company markets its own brand of ertapenem through hospital networks across China and Southeast Asia.

Regional Strengths:

• Strong formulary positions in China
• Growing export business
• Government contract experience

Get Full Report Here:
https://www.24chemicalresearch.com/reports/277305/global-ertapenem-for-injection-market-2024-224

---

🏥 Market Outlook: Evolving Dynamics in Ertapenem Therapeutics

The global ertapenem market faces changing dynamics driven by increasing generic competition, antimicrobial stewardship programs, and evolving treatment guidelines for resistant infections.

📈 Key Market Trends:

• Expanding outpatient parenteral antibiotic therapy (OPAT) adoption
• Strategic partnerships between manufacturers and healthcare systems
• Emerging market growth outpacing developed regions
• Increasing procurement through group purchasing organizations

Get Full Report Here:
https://www.24chemicalresearch.com/reports/277305/global-ertapenem-for-injection-market-2024-224

The featured companies represent the pharmaceutical industry’s response to the critical need for effective antibiotics against resistant pathogens, balancing therapeutic innovation with sustainable access.